DKK2 and neoplasm: To further determine whether DKK2 neutralization similarly enhances ICB responsiveness, MC38 tumor-bearing mice were treated with anti-Dkk2 (5F8) alone or in combination with anti–PD-1 (Supplemental Figure 10D).